手术后恶心和吐背后的神经机制和途径:综合性综述
1The First Clinical Institute, Zunyi Medical University, Zunyi City, 563000, Guizhou Province, China.
European journal of medical research
|May 5, 2025
概括
手术后恶心和吐 (PONV) 涉及复杂的神经通路,包括单独通道的核. 本综述综合了有关这些途径和影响因素的当前证据,以更好地理解和管理PONV.
科学领域:
- 神经科学是一个神经科学.
- 麻醉学 麻醉学
- 胃肠病学 胃肠病学
背景情况:
- 手术后恶心和吐 (PONV) 是麻醉和手术后的常见并发症.
- PONV可以引起患者显著的不适,并延长恢复时间.
- 确定PONV的神经支对于开发有效干预措施至关重要.
研究的目的:
- 综合当前关于PONV.中涉及的神经机制和途径的证据.
- 探索影响PONV发生和严重程度的因素.
- 提供关于PONV神经生物学研究进展的最新概述.
主要方法:
- 一个系统的文献范围审查.
- 在PubMed,Embase和Cochrane图书馆数据库中进行的搜索.
- 包括到2024年发表的研究.
主要成果:
- 多种不同的外科手术和麻醉剂会触发PONV.
- 证据表明神经通路的复杂相互作用,可能涉及一个中央模式生成器.
- 关键的神经结构涉及的包括孤独通道的核和第十神经的背部核.
结论:
- PONV的结果来自复杂的神经信号,而不是孤立的途径.
- 一个中央神经网络整合了导致PONV的信号.
- 对这些途径的进一步研究可以改善PONV预防和治疗策略.
相关概念视频
Pathophysiology of Vomiting
244
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
244
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
137
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
137
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
151
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
151
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
187
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
187
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
184
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
184
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


